Rivaroxaban in Left Ventricular Thrombus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 261 participants.
Also called NCT04970576
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 261 participants
- Registry
-
NCT04970576
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Pakistan
- Registry status
- Completed
Technical summary
Registry record NCT04970576. Randomized; single masking; primary purpose treatment. Start 2021-06-25 (actual); primary completion 2024-05-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rivaroxaban in Left Ventricular Thrombus
- Condition
- Acute Coronary Syndrome
- Condition
- Left Ventricular Thrombus
- Intervention (Drug)
- Rivaroxaban
- Intervention (Drug)
- Warfarin
- Lead sponsor
- National Institute of Cardiovascular Diseases, Pakistan
Record details
- Record id
cardio:ct-nct04970576- Content hash
c92f96fd8e9f8bb9ffd20ecd36cff112b7575f6ee7493548c61b6e29091fd35a